Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Rodabe N Amaria,1 Alexandre Reuben,2 Zachary A Cooper,2,3 Jennifer A Wargo2,3 1Department of Melanoma Medical Oncology, 2Department of Surgical Oncology, 3Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: High-dose interleukin-2 has been used...

Full description

Bibliographic Details
Main Authors: Amaria RN, Reuben A, Cooper ZA, Wargo JA
Format: Article
Language:English
Published: Dove Medical Press 2015-04-01
Series:ImmunoTargets and Therapy
Subjects:
aldesleukin
melanoma
immunotherapy
Online Access:https://www.dovepress.com/update-on-use-of-aldesleukin-for-treatment-of-high-risk-metastatic-mel-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/update-on-use-of-aldesleukin-for-treatment-of-high-risk-metastatic-mel-peer-reviewed-article-ITT

Similar Items